Corcept Therapeutics Incorporated

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
218352102
SEDOL
BG05S68
CIK
0001088856
www.corcept.com
LEI:
©
FIGI: BBG000BKJG33
CORT
Corcept Therapeutics Incorporated
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
AI
PROFILER
NAME
Corcept Therapeutics Incorporated
ISIN
US2183521028
TICKER
CORT
MIC
XNAS
REUTERS
CORT.OQ
BLOOMBERG
CORT US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
TradingView ActivTrader MT4 MT5
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 16.12.2024       Corcept Therapeutics
US2183521028

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, presented results from its Phase 3 long-term, open-label extension study of relacorilan...
Read More
Corcept Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Thu, 12.12.2024       Corcept Therapeutics
US2183521028

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the primary endpoint was met in the treatment phase of CATALYST, a...
Read More
Corcept Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 11.12.2024       Corcept Therapeutics
US2183521028

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol, today announced results from the DAZALS study, a randomized, double-blind, placebo-con...
Read More
Corcept Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 30.10.2024       Corcept Therapeutics
US2183521028

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today reported its results for the quarter ended September 30, 2024. Financial Results...
Read More
Corcept Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 23.10.2024       Corcept Therapeutics
US2183521028

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on October 30, 2024. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conf...
Read More
Corcept Therapeutics
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S